查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全基因組測序市場 - 2018-2028 年全球行業規模、佔有率、趨勢、競爭、機會及預測。按測序類型、按產品類型、按應用、按最終用戶、按地區和競爭情況分類
市場調查報告書
商品編碼
1309867

全基因組測序市場 - 2018-2028 年全球行業規模、佔有率、趨勢、競爭、機會及預測。按測序類型、按產品類型、按應用、按最終用戶、按地區和競爭情況分類

Whole Genome Sequencing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028. Segmented By Sequencing Type, By Product Type, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

在2024-2028 年的預測期內，全基因組測序市場預計將以驚人的複合年成長率成長。這可歸因於以下因素

技術不斷進步

NGS 儀器技術的不斷進步和測序技術的更新將進一步推動測序市場在預測期內的成長。此外，與毛細管測序或基於PCR 的方法不同，下一代測序（NGS）具有復用功能，使微生物研究人員能夠對數百種生物進行測序。基於NGS 的微生物基因組測序不僅省時高效，而且簡化了工作流程，不像老式技術那樣依賴於耗時的克隆階段。此外，可能會被忽視的低頻變異和基因組重排，使用現有技術發現成本太高，而使用NGS（下一代測序）則可以發現。此外，當今時代的群體級WES（全外顯子組測序）數據生成量也在增加。全外顯子組測序（WES）是測序領域的一項成功應用，孟德爾表型、米勒氏病等疾病的基因的發現證明了這一點。全外顯子測序比全基因組測序更有用，因為大多數已知的致病突變都發生在外顯子中，市場需求量很大，因此預計未來將推動市場成長。

疾病診斷需求不斷成長

全基因組測序在疾病診斷方面的臨床應用需求日益成長，在鑑定基因組片段突變以分離基因變異或突變方面具有重要意義。此外，微生物全基因組重測序等技術涉及對細菌、病毒或其他微生物的整個基因組進行測序，並將測序結果與已知參照物的序列進行比較，因此有助於疾病診斷。因此，這種微生物基因組測序是微生物鑑定的重要工具。此外，全基因組測序技術還可用於識別生物體內鹼基的排列順序，從而生成精確的DNA 指紋，有助於將病例聯繫起來，快速檢測出疾病的爆發或缺陷，因此在傳染病診斷方面具有重要意義，從而促進預測期內的市場成長。

基因組測繪應用增加

政府項目對基因組測繪的需求不斷增加，因為與疾病診斷和研究有關的研發工作日益增多，以改善癌症、突變性疾病和其他疾病的治療等。此外，不同國家和地區的政府正在對數百萬個基因組進行測序，以促進研究，發現更好的方法來識別和治療癌症、不常見疾病和其他疾病。例如，歐洲政府正在通過法國的"2025 年法國基因組醫學計劃"和英國的"10 萬基因組計劃"等項目，努力改善該地區的大規模基因組數據。這些計劃促進了NGS 下一代測序（NGS）資訊學服務在該地區的發展。例如，2022 年11 月，斯坦福醫科大學的科學家利用奈米孔基因組測序、人工智慧和雲端運算，在不到5 個小時的時間內完成了一名患者的全基因組測序。

最新進展

2021 年11 月， Illumina 和基因聯盟宣布了一項價值1.2 億美元的全球計劃- iHope 基因健康計劃。該計劃旨在為全球各種受遺傳疾病影響的患者提供全基因組測序（WGS）服務。

此外，2020 年，領先企業QIAGEN 收購了NeuMoDx Molecular，鞏固了其在自動化分子檢測市場的地位。現在，該公司將基於PCR 檢測技術的中高通量NeuMoDx 自動化解決方案作為其最新產品組合的新組成部分。

可客製化

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。報告可提供以下客製化選項：

公司資訊

  • 其他市場參與者（最多五家）的詳細分析和概況。

目錄

第1 章：服務概述

  • 市場定義
  • 市場範圍
    • 市場覆蓋範圍
    • 研究年份
    • 主要市場細分

第2 章：研究方法

  • 研究目標
  • 基準方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第3 章：執行摘要

  • 市場概述
  • 主要市場細分概述
  • 主要市場參與者概述
  • 主要地區/國家概述
  • 市場驅動因素、挑戰和趨勢概述

第4章：客戶之聲

第5章：全基因組測序市場前景。

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按測序類型（大型全基因組測序和小型基因組測序）
    • 按產品類型（儀器、試劑盒和服務）
    • 按應用（診斷、藥物發現與開發、個性化醫療及其他）
    • 按最終用戶（醫院和診所、製藥和生物技術公司及其他）
    • 按公司（2022 年）
    • 按地區
  • 市場地圖
    • 按測序類型
    • 按產品類型
    • 按應用
    • 按最終用戶
    • 按地區

第6章：亞太地區全基因組測序市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 測序類型
    • 產品類型
    • 應用
    • 終端用戶
    • 按國家分類
  • 亞太地區：國家分析
    • 中國.
    • 印度.
    • 印度.
    • 日本
    • 澳大利亞

第7 章: 歐洲全基因組測序市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 測序類型
    • 產品類型
    • 應用
    • 終端用戶
    • 按國家分類
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8 章：北美全基因組測序市場前景。

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 測序類型
    • 產品類型
    • 應用
    • 終端用戶
    • 按國家分類
  • 北美洲：國家分析
    • 美國全基因組測序市場前景
      • 市場規模與預測
        • 按價值
      • 市場佔有率與預測
        • 測序類型
        • 產品類型
        • 應用
        • 終端用戶
    • 墨西哥全基因組測序市場前景
      • 市場規模與預測
        • 按價值
      • 市場佔有率與預測
        • 測序類型
        • 產品類型
        • 應用
        • 終端用戶
    • 加拿大全基因組測序市場前景
      • 市場規模與預測
        • 按價值
      • 市場佔有率與預測
        • 測序類型
        • 產品類型
        • 應用
        • 終端用戶

第9 章: 南美洲全基因組測序市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 測序類型
    • 產品類型
    • 應用
    • 終端用戶
    • 按國家分類
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10 章: 中東和非洲全基因組測序市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 測序類型
    • 產品類型
    • 應用
    • 終端用戶
    • 按國家
  • 中東和非洲：國家分析
    • 南非全基因組測序
    • 沙烏地阿拉伯全基因組測序
    • 阿拉伯聯合大公國全基因組測序
    • 科威特全基因組測序

第11 章：市場動態

  • 驅動因素
  • 挑戰

第12 章：市場趨勢與發展

  • 近期動態
  • 合併與收購
  • 產品開發

第13 章：競爭格局

  • 業務概述
  • 公司概況
  • 產品與服務
  • 財務狀況（上市公司）
  • 近期發展
  • SWOT 分析
    • GE Healthcare, Inc.
    • Illumina, Inc.
    • QIAGEN NV
    • Thermo Fisher Scientific
    • Agilent Technologies
    • 10 x Genomics
    • BGI
    • Oxford Nanopore
    • Nebula Genomics
    • Veritas Genetics.

第14 章：戰略建議

簡介目錄
Product Code: 14973

Whole Genome Sequencing Market is expected to grow with an impressive CAGR in the forecast period 2024-2028. This can be attributed to factors such as

Whole Genome Sequencing Market (WGS) is a widely used application included in genome, microbial resequencing, and genome sequencing. It is expected to increase significantly with the growing research in genomics. Additionally, a rise in the usage of this technology against COVID-19 in sequencing the data of the COVID-19 virus is expected to drive market growth.

Whole Genome Sequencing Market (WGS) technology can deliver quick results and high-quality data. It can be used to locate, monitor, and address disease outbreaks in a region. WGS is shown to be most useful in research and rarely in therapeutic treatments.

The mapping of novel organisms' genomes, the completion of the genomes of already-known organisms, or the comparison of genomes from other samples all benefit from microbial whole-genome sequencing. To create reliable reference genomes, microbial identification, and other comparative genomic investigations, it is required to sequence the full bacterial, viral, and other microbial genomes.

Growing Technological Advancement

Increasing technological advancement in NGS instruments and update in technology utilized in Sequencing techniques are adding to further drive the sequencing market growth in the forecast period. Moreover, with its multiplexing feature, next-generation sequencing (NGS) enables microbiology researchers to sequence hundreds of organisms, unlike capillary sequencing or PCR-based methods. NGS-based microbial genome sequencing is time efficient and streamlines the workflow, and does not rely on time-consuming cloning stages like older techniques. Additionally, low-frequency variations and genomic rearrangements that might be overlooked are too expensive to find using current techniques that can be found using NGS (Next Generation Sequencing). Also, population-level WES (whole exome sequencing) data generation has increased in today's time. Whole exome sequencing (WES) is a successful application in the field of sequencing and is proved by the discovery of the genes for the conditions such as Mendelian phenotypes, Miller's disease, and other diseases. Whole exome sequencing is more useful than whole genome sequencing since the majority of known disease-causing mutations take place in exons and are in high demand in the market and thus anticipated to propel the market growth in the future.

Growing Demand in Disease Diagnosis

Whole genome sequencing has an increased demand in clinical applications regarding disease diagnosis and has significant importance in the identification of a mutation in a genome segment for isolating a variant or mutation in a gene. Moreover, techniques such as Microbial whole-genome resequencing involve the sequencing of the entire genome of a bacteria, virus, or other microbe and comparing the sequence to that of a known reference and thus is helpful in disease diagnosis. This microbial genome sequencing is thus an important tool for microbial identification. Additionally, the whole genome sequencing technique is used for identifying the order of bases in the organism and is thus utilized to produce a precise DNA fingerprint and thus can aid in linking the cases allowing the eruption or defect to be detected quickly and, thus, is significant in infectious disease diagnosis to bolster the market growth in the forecast period.

Increased Application in Genome Mapping

The rising demand for genome mapping in government projects for the rising research and development related to disease diagnosis and research for improved treatment in cancer, mutated disorders, and other diseases, etc. Furthermore, governments of distinct countries and regions are sequencing millions of genomes to progress research and discover better ways to identify and cure cancer, uncommon disorders, and other ailments. For instance, the European government is undertaking efforts to improve the region's large-scale genomic data with projects such as France's French Plan for Genomic Medicine 2025 and, similarly, the United Kingdom's 100,000 Genomes Project. These initiatives have resulted in the growth of NGS's Next-generation sequencing (NGS) informatics services in the region. For instance, in November 2022, using Nanopore Genome Sequencing, AI, and Cloud Computing, scientists at Stanford Medicine University sequenced a patient's whole genome in under five hours.

Recent Developments

In November 2021, Illumina and Genetic Alliance announced a USD 120 million global initiative-the iHope Genetic Health program. This initiative aims to offer Whole Genome Sequencing (WGS) access to various patients impacted by genetic disorders globally.

Also, In 2020, a leading company QIAGEN acquired NeuMoDx Molecular and secured its position in the market in automated molecular testing. The company now includes medium- and high-throughput NeuMoDx automation solutions based on PCR testing technology as a new component of its updated product portfolio.

Market Segmentation

The whole Genome Sequencing Market is segmented based on the sequencing type, product type, application, end-user, and region. Based on sequencing type, the market is segmented into large whole-genome sequencing and small-genome sequencing. Based on product type, the market is segmented into instruments, kits, and services. Based on application, the market is segmented into diagnostics, drug discovery and development, personalized medicine, and others. Based on end users, the market is further fragmented into hospitals and clinics, pharmaceutical and biotechnology companies, and others. Based on the region, the market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

GE Healthcare, Inc., Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific, Agilent Technologies, 10 x Genomics, BGI, Oxford Nanopore, Nebula Genomics, Veritas Genetics, etc.., are some of the major players operating in the global Whole Genome Sequencing Market.

Report Scope

In this report, Whole Genome Sequencing Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Whole Genome Sequencing Market, By Sequencing Type:

  • Large Whole-Genome Sequencing
  • Small Genome Sequencing

Whole Genome Sequencing Market, By Product Type:

  • Instrument
  • Kits
  • Service

Whole Genome Sequencing Market, By Application:

  • Diagnostics
  • Drug Discovery and Development
  • Personalized Medicine
  • Others

Whole Genome Sequencing Market, By End User:

  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Whole Genome Sequencing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
  • South America
    • Brazil
    • Argentina
    • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Whole Genome Sequencing Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered.
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Whole Genome Sequencing Market Outlook.

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sequencing Type (Large Whole-Genome Sequencing and Small Genome Sequencing)
    • 5.2.2. By Product Type (Instrument, Kits, and Service)
    • 5.2.3. By Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others)
    • 5.2.4. By End User (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Others)
    • 5.2.5. By Company (2022)
    • 5.2.6. By Region
  • 5.3. Market Map
    • 5.3.1. By Sequencing Type
    • 5.3.2. By Product Type
    • 5.3.3. By Application
    • 5.3.4. By End User
    • 5.3.5. By Region

6. Asia-Pacific Whole Genome Sequencing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. Sequencing Type
    • 6.2.2. Product Type
    • 6.2.3. Application
    • 6.2.4. End User
    • 6.2.5. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Whole Genome Sequencing Market Outlook.
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. Sequencing Type
        • 6.3.1.2.2. Product Type
        • 6.3.1.2.3. Application
        • 6.3.1.2.4. End User
    • 6.3.2. India Whole Genome Sequencing Market Outlook.
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. Sequencing Type
        • 6.3.2.2.2. Product Type
        • 6.3.2.2.3. Application
        • 6.3.2.2.4. End User
    • 6.3.3. South Korea Whole Genome Sequencing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. Sequencing Type
        • 6.3.3.2.2. Product Type
        • 6.3.3.2.3. Application
        • 6.3.3.2.4. End User
    • 6.3.4. Japan Whole Genome Sequencing Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. Sequencing Type
        • 6.3.4.2.2. Product Type
        • 6.3.4.2.3. Application
        • 6.3.4.2.4. End User
    • 6.3.5. Australia Whole Genome Sequencing Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. Sequencing Type
        • 6.3.5.2.2. Product Type
        • 6.3.5.2.3. Application
        • 6.3.5.2.4. End User

7. Europe Whole Genome Sequencing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. Sequencing Type
    • 7.2.2. Product Type
    • 7.2.3. Application
    • 7.2.4. End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Whole Genome Sequencing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. Sequencing Type
        • 7.3.1.2.2. Product Type
        • 7.3.1.2.3. Application
        • 7.3.1.2.4. End User
    • 7.3.2. Germany Whole Genome Sequencing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. Sequencing Type
        • 7.3.2.2.2. Product Type
        • 7.3.2.2.3. Application
        • 7.3.2.2.4. End User
    • 7.3.3. United Kingdom Whole Genome Sequencing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. Sequencing Type
        • 7.3.3.2.2. Product Type
        • 7.3.3.2.3. Application
        • 7.3.3.2.4. End User
    • 7.3.4. Italy Whole Genome Sequencing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. Sequencing Type
        • 7.3.4.2.2. Product Type
        • 7.3.4.2.3. Application
        • 7.3.4.2.4. End User
    • 7.3.5. Spain Whole Genome Sequencing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. Sequencing Type
        • 7.3.5.2.2. Product Type
        • 7.3.5.2.3. Application
        • 7.3.5.2.4. End User

8. North America Whole Genome Sequencing Market Outlook.

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. Sequencing Type
    • 8.2.2. Product Type
    • 8.2.3. Application
    • 8.2.4. End User
    • 8.2.5. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Whole Genome Sequencing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. Sequencing Type
        • 8.3.1.2.2. Product Type
        • 8.3.1.2.3. Application
        • 8.3.1.2.4. End User
    • 8.3.2. Mexico Whole Genome Sequencing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. Sequencing Type
        • 8.3.2.2.2. Product Type
        • 8.3.2.2.3. Application
        • 8.3.2.2.4. End User
    • 8.3.3. Canada Whole Genome Sequencing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. Sequencing Type
        • 8.3.3.2.2. Product Type
        • 8.3.3.2.3. Application
        • 8.3.3.2.4. End User

9. South America Whole Genome Sequencing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. Sequencing Type
    • 9.2.2. Product Type
    • 9.2.3. Application
    • 9.2.4. End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Whole Genome Sequencing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. Sequencing Type
        • 9.3.1.2.2. Product Type
        • 9.3.1.2.3. Application
        • 9.3.1.2.4. End User
    • 9.3.2. Argentina Whole Genome Sequencing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. Sequencing Type
        • 9.3.2.2.2. Product Type
        • 9.3.2.2.3. Application
        • 9.3.2.2.4. End User
    • 9.3.3. Colombia Whole Genome Sequencing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. Sequencing Type
        • 9.3.3.2.2. Product Type
        • 9.3.3.2.3. Application
        • 9.3.3.2.4. End User

10. Middle East and Africa Whole Genome Sequencing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. Sequencing Type
    • 10.2.2. Product Type
    • 10.2.3. Application
    • 10.2.4. End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Whole Genome Sequencing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. Sequencing Type
        • 10.3.1.2.2. Product Type
        • 10.3.1.2.3. Application
        • 10.3.1.2.4. End User
    • 10.3.2. Saudi Arabia Whole Genome Sequencing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. Sequencing Type
        • 10.3.2.2.2. Product Type
        • 10.3.2.2.3. Application
        • 10.3.2.2.4. End User
    • 10.3.3. UAE Whole Genome Sequencing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. Sequencing Type
        • 10.3.3.2.2. Product Type
        • 10.3.3.2.3. Application
        • 10.3.3.2.4. End User
    • 10.3.4. Kuwait Whole Genome Sequencing Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. Sequencing Type
        • 10.3.4.2.2. Product Type
        • 10.3.4.2.3. Application
        • 10.3.4.2.4. End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Developments

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Company Snapshot
  • 13.3. Products & Services
  • 13.4. Financials (In case of listed companies)
  • 13.5. Recent Developments
  • 13.6. SWOT Analysis
    • 13.6.1. GE Healthcare, Inc.
    • 13.6.2. Illumina, Inc.
    • 13.6.3. QIAGEN N.V.
    • 13.6.4. Thermo Fisher Scientific
    • 13.6.5. Agilent Technologies
    • 13.6.6. 10 x Genomics
    • 13.6.7. BGI
    • 13.6.8. Oxford Nanopore
    • 13.6.9. Nebula Genomics
    • 13.6.10. Veritas Genetics.

14. Strategic Recommendations